Prevalence and Clinical Correlates of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Patients

Background: Metabolic syndrome is a cluster of metabolic abnormalities including central obesity, hypertension, dyslipidemia, and impaired glucose metabolism that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. The coexistence of metabolic syndrome in diabetic patients further increases the risk of cardiovascular complications and mortality. Early identification of metabolic syndrome among newly diagnosed diabetic patients is therefore important for timely intervention and prevention of long-term complications. Aim of the study was to determine the prevalence of metabolic syndrome among newly diagnosed type 2 diabetes mellitus patients and to evaluate its association with anthropometric, clinical, and biochemical parameters.

Material and Methods: This cross-sectional observational study was conducted among 100 patients with newly diagnosed type 2 diabetes mellitus attending the Department of General Medicine at NRI Medical College. Anthropometric measurements including body mass index, waist circumference, and waist–hip ratio were recorded. Clinical parameters such as systolic and diastolic blood pressure were measured. Biochemical investigations including fasting blood glucose, postprandial blood glucose, HbA1c, and lipid profile were analyzed. The presence of metabolic syndrome was assessed using standard diagnostic criteria. Statistical analysis was performed using the chi-square test and Student’s t-test.

Results: Metabolic syndrome was present in 41% of patients with newly diagnosed type 2 diabetes mellitus. Patients with metabolic syndrome had significantly higher body mass index, waist circumference, waist–hip ratio, systolic and diastolic blood pressure, fasting blood glucose, postprandial blood glucose, HbA1c levels, and triglyceride levels. HDL cholesterol levels were significantly lower among patients with metabolic syndrome. However, LDL cholesterol, VLDL cholesterol, and total cholesterol levels did not show statistically significant differences between the groups.

Conclusion: Metabolic syndrome is highly prevalent among newly diagnosed type 2 diabetes mellitus patients. Early screening and management of metabolic syndrome components are essential to reduce cardiovascular risk and improve long-term outcomes.